Welcome to our dedicated page for Guardian Pharmacy Services SEC filings (Ticker: GRDN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Guardian Pharmacy Services, Inc. filings document the reporting obligations of a NYSE-listed long-term care pharmacy services company with Class A common stock. Recent Form 8-K filings furnish operating results, financial guidance, investor presentation materials, and exhibits tied to the company’s pharmacy services business.
Proxy and current-report filings also cover board elections, advisory compensation votes, stockholder voting results, material stock purchase agreements, lock-up arrangements, and conversion-related disclosures involving Class A and Class B common stock. These records describe governance, ownership, capital-structure mechanics, registered securities, and matters linked to the company’s September 2024 corporate reorganization.
Brown Advisory Inc and affiliated entities filed an amended Schedule 13G reporting their passive ownership in Guardian Pharmacy Services, Inc. They disclose beneficial ownership of 1,644,569 shares of Class A common stock, representing 4.54% of the class as of 12/31/2025.
The shares are held across Brown Advisory Inc, Brown Investment Advisory & Trust Co, Brown Advisory LLC, Signature Financial Management, Inc., and Brown Advisory Ltd, through investment companies and other managed accounts. The group certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Guardian Pharmacy Services.
Guardian Pharmacy Services, Inc. (GRDN) received an amended Schedule 13G from a Wellington-affiliated group reporting a minority ownership position. Wellington Management Group LLP, Wellington Group Holdings LLP, and Wellington Investment Advisors Holdings LLP report beneficial ownership of 1,123,132 shares of common stock, representing 3.1% of the class as of the event date 12/31/2025.
The group reports no sole voting or dispositive power, with shared voting power over 793,969 shares and shared dispositive power over 1,123,132 shares. The securities are owned of record by clients of Wellington investment advisers, and no individual client is said to hold more than five percent of the class. The filing certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Guardian Pharmacy Services.
BlackRock, Inc. reports a passive ownership stake in Guardian Pharmacy Services, Inc. Class A stock. As of the event date, BlackRock beneficially owned 1,507,822 Class A shares, representing 4.2% of the class. It held sole voting power over 1,473,050 shares and sole dispositive power over 1,507,822 shares, with no shared voting or dispositive power.
The filing is an amended Schedule 13G/A, indicating that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Guardian Pharmacy Services. Various underlying clients have rights to dividends or sale proceeds, but no single client has more than five percent of the total outstanding common shares.
Guardian Pharmacy Services, Inc. reiterated its previously issued financial guidance for the full year ended December 31, 2025 and shared an early financial outlook for 2026. These updates were released through a press release that is furnished as an exhibit.
The company also prepared an investor presentation about its business for use at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at approximately 4:30 p.m. Pacific Time, as well as in meetings with investors, analysts, and other interested parties. Both the press release and the presentation are provided as supplemental materials to inform the market about current expectations and business positioning.
Guardian Pharmacy Services reported an insider stock gift by its President, Chief Executive Officer and Director. On 12/04/2025, the reporting person made a bona fide gift of 200,000 shares of Class A common stock, coded as a gift transaction, at a reported price of $0 per share.
The shares were donated to a charitable donor-advised fund, which agreed not to sell or transfer the shares during a lock-up period that expires on June 30, 2026, and to hold the shares in its account for up to three years from the gift date. After this transaction, the reporting person beneficially owned 1,511,845 shares of Class A common stock, held directly.
Guardian Pharmacy Services, Inc. Executive Vice President of Sales & Operations reported a charitable stock gift in this filing. On 12/04/2025, the insider made a bona fide gift of 21,500 shares of Class A common stock, recorded at a price of $0 as is typical for gifts. After this transaction, the reporting person beneficially owns 790,976 shares directly.
The shares were donated to a charitable donor-advised fund, which has agreed not to sell or transfer the shares during a lock-up period that runs until June 30, 2026. The filing is made by a single reporting person and reflects a transfer for charitable purposes rather than an open-market sale.
Guardian Pharmacy Services, Inc. reported an insider share purchase by a company director. On 12/03/2025, the director bought 3,370 shares of Class A common stock, coded as a purchase ("P") transaction.
The filing states a weighted-average purchase price of $29.61 per share, with individual trades executed between $29.31 and $29.80. After this transaction, the director beneficially owns 24,984 shares of Guardian Pharmacy Services, Inc. common stock in direct ownership.
J. Goldman & Co., L.P. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 656,860 shares of Guardian Pharmacy Services, Inc. common stock, representing 2.9% of the class as of the event date 09/30/2025.
The filing is jointly made by J. Goldman & Co., L.P., J. Goldman Capital Management, Inc., and Jay G. Goldman. Each reports 0 shares with sole voting or dispositive power and 656,860 shares with shared voting and shared dispositive power. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Wellington Management Group LLP, together with affiliated entities, filed a Schedule 13G reporting beneficial ownership of 1,143,729 shares of Guardian Pharmacy Services, Inc. (GRDN), representing 5.03% of the common stock as of 09/30/2025.
The filing shows shared voting power: 803,853 shares and shared dispositive power: 1,143,729 shares, with no sole voting or dispositive power. The securities are owned of record by clients of Wellington’s investment advisers. The filer certifies the holdings were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Guardian Pharmacy Services (GRDN) reported stronger Q3 results. Revenue rose to $377.4 million, up 20% from $314.4 million a year ago, as the company served more residents and filled more prescriptions. Gross profit reached $74.7 million. Selling, general and administrative costs dropped to $58.4 million, reflecting much lower share-based compensation versus the 2024 IPO period.
Operating income was $16.4 million compared with a loss last year. Net income was $9.6 million, with diluted EPS of $0.15; for the first nine months, net income was $27.7 million and diluted EPS was $0.45. Cash and cash equivalents were $36.5 million, up from $4.7 million at year-end. The business served about 204,000 residents across roughly 8,200 long‑term care facilities in 38 states as of September 30, 2025.
In 2025, the company completed acquisitions with total preliminary consideration of $16.3 million, contributing $16.2 million of Q3 revenue. Interest expense declined as there were no outstanding balances under the credit facility during the period.